Hafron J - Search Results

1

Quarles J, Hafron J. Quarles J, et al. Among authors: hafron j. Urol Clin North Am. 2021 May;48(2):195-202. doi: 10.1016/j.ucl.2020.12.001. Epub 2021 Mar 10. Urol Clin North Am. 2021. PMID: 33795053 Review.

2

Editorial Comment.

Hafron J, Zwaans BMM. Hafron J, et al. J Urol. 2024 Jun;211(6):773-774. doi: 10.1097/JU.0000000000003935. Epub 2024 May 9. J Urol. 2024. PMID: 38721937 No abstract available.

3

Prevalence and Causes of Discontinuation of Androgen Receptor Inhibitors in Advanced Prostate Cancer Patients and Analysis of Physician Management to Increase Duration of Therapy.

Gangwish D, Zwaans BMM, Miriani P, Dejoie W, Ajo A, Ervin C, Sarazin J, Hafron J. Gangwish D, et al. Among authors: hafron j. Urology. 2023 Mar;173:142-148. doi: 10.1016/j.urology.2022.12.025. Epub 2023 Jan 2. Urology. 2023. PMID: 36603654

4

Characterization of clear cell renal cell carcinoma by gene expression profiling.

Thibodeau BJ, Fulton M, Fortier LE, Geddes TJ, Pruetz BL, Ahmed S, Banes-Berceli A, Zhang PL, Wilson GD, Hafron J. Thibodeau BJ, et al. Among authors: hafron j. Urol Oncol. 2016 Apr;34(4):168.e1-9. doi: 10.1016/j.urolonc.2015.11.001. Epub 2015 Dec 3. Urol Oncol. 2016. PMID: 26670202

5

Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinoma.

Zhang PL, Mashni JW, Sabbisetti VS, Schworer CM, Wilson GD, Wolforth SC, Kernen KM, Seifman BD, Amin MB, Geddes TJ, Lin F, Bonventre JV, Hafron JM. Zhang PL, et al. Among authors: hafron jm. Int Urol Nephrol. 2014 Feb;46(2):379-88. doi: 10.1007/s11255-013-0522-z. Epub 2013 Aug 25. Int Urol Nephrol. 2014. PMID: 23979814 Free PMC article.

6

Progenitor/stem cells in renal regeneration and mass lesions.

Zhang PL, Hafron JM. Zhang PL, et al. Int Urol Nephrol. 2014 Nov;46(11):2227-36. doi: 10.1007/s11255-014-0821-z. Epub 2014 Sep 3. Int Urol Nephrol. 2014. PMID: 25181957 Review.

7

Diagnostic role of kidney injury molecule-1 in renal cell carcinoma.

Zhang KJ, Wilson GD, Kara S, Majeske A, Zhang PL, Hafron JM. Zhang KJ, et al. Among authors: hafron jm. Int Urol Nephrol. 2019 Nov;51(11):1893-1902. doi: 10.1007/s11255-019-02231-0. Epub 2019 Aug 5. Int Urol Nephrol. 2019. PMID: 31385177 Review.

8

Real-World Effectiveness of Sipuleucel-T on Overall Survival in Men with Advanced Prostate Cancer Treated with Androgen Receptor-Targeting Agents.

Hafron JM, Wilfehrt HM, Ferro C, Harmon M, Flanders SC, McKay RR. Hafron JM, et al. Adv Ther. 2022 Jun;39(6):2515-2532. doi: 10.1007/s12325-022-02085-6. Epub 2022 Mar 30. Adv Ther. 2022. PMID: 35352309 Free PMC article.

9

Benign prostate hyperplasia as a potential protective factor against prostate cancer: Insights from a magnetic resonance imaging study of compositional characteristics.

Nandalur KR, Colvin R, Walker D, Nandalur SR, Seifman B, Gangwish D, Hafron J. Nandalur KR, et al. Among authors: hafron j. Prostate. 2021 Oct;81(14):1097-1104. doi: 10.1002/pros.24207. Epub 2021 Aug 10. Prostate. 2021. PMID: 34375453

10

Chromogranin A staining as a prognostic variable in newly diagnosed Gleason score 7-10 prostate cancer treated with definitive radiotherapy.

Krauss DJ, Amin M, Stone B, Ye H, Hayek S, Cotant M, Hafron J, Brabbins DS. Krauss DJ, et al. Among authors: hafron j. Prostate. 2014 May;74(5):520-7. doi: 10.1002/pros.22771. Epub 2013 Dec 30. Prostate. 2014. PMID: 24375481

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page